SIGA Technologies, Inc. (SIGA)
NASDAQ: SIGA · Real-Time Price · USD
6.46
-0.10 (-1.52%)
At close: Jun 27, 2025, 4:00 PM
6.46
0.00 (-0.02%)
After-hours: Jun 27, 2025, 7:21 PM EDT
SIGA Technologies Market Cap
SIGA Technologies has a market cap or net worth of $461.51 million as of June 27, 2025. Its market cap has decreased by -16.59% in one year.
Market Cap
461.51M
Enterprise Value
300.46M
1-Year Change
-16.59%
Ranking
Category
Stock Price
$6.46
Market Cap Chart
Since December 1, 1998, SIGA Technologies's market cap has increased from $199.10M to $461.51M, an increase of 131.80%. That is a compound annual growth rate of 3.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 468.70M | 9.23% |
| Dec 31, 2024 | 429.10M | 7.79% |
| Dec 29, 2023 | 398.10M | -25.93% |
| Dec 30, 2022 | 537.50M | -3.57% |
| Dec 31, 2021 | 557.40M | -0.94% |
| Dec 31, 2020 | 562.70M | 45.51% |
| Dec 31, 2019 | 386.70M | -39.06% |
| Dec 31, 2018 | 634.60M | 65.82% |
| Dec 29, 2017 | 382.70M | 144.85% |
| Dec 30, 2016 | 156.30M | 588.55% |
| Dec 31, 2015 | 22.70M | -70.52% |
| Dec 31, 2014 | 77.00M | -55.57% |
| Dec 31, 2013 | 173.30M | 28.09% |
| Dec 31, 2012 | 135.30M | 4.40% |
| Dec 30, 2011 | 129.60M | -80.68% |
| Dec 31, 2010 | 670.80M | 201.75% |
| Dec 31, 2009 | 222.30M | 92.30% |
| Dec 31, 2008 | 115.60M | 10.73% |
| Dec 31, 2007 | 104.40M | -12.34% |
| Dec 29, 2006 | 119.10M | 372.62% |
| Dec 30, 2005 | 25.20M | -38.08% |
| Dec 31, 2004 | 40.70M | -4.91% |
| Dec 31, 2003 | 42.80M | -81.27% |
| Dec 29, 2000 | 228.50M | 94.14% |
| Dec 31, 1999 | 117.70M | 13.06% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.12B |
| Johnson & Johnson | 367.94B |
| AbbVie | 330.23B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 277.36B |
| Abbott Laboratories | 238.86B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |